• Molecular NameL-Isoleucine
  • Synonym(2S,3S)-2-Amino-3-methylpentanoic acid; (2S,3S)-a-Amino-b-methyl-n-valeric acid; (2S,3S)-a-Amino-b-methylvaleric acid; (S,S)-Isoleucine; (S)-Isoleucine; 2-Amino-3-methylvaleric acid; 2S,3S-Isoleucine; erythro-L-Isoleucine; Isoleucine; L-(+)-Isoleucine; L-Ile
  • Weight131.175
  • Drugbank_IDDB00167
  • ACS_NO73-32-5
  • Show 3D model
  • LogP (experiment)-1.76
  • LogP (predicted, AB/LogP v2.0)-1.8
  • pkaN/A
  • LogD (pH=7, predicted)-1.8
  • Solubility (experiment)33.7 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-0.09
  • LogSw (predicted, AB/LogsW2.0)24.73
  • Sw (mg/ml) (predicted, ACD/Labs)106.5
  • No.of HBond Donors3
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds3
  • TPSA63.32
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyN/A
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A